Hot sale Tilmicosin Injectable - Tylosin Tartrate Injection – Jizhong
Hot sale Tilmicosin Injectable - Tylosin Tartrate Injection – Jizhong Detail:
Tylosin Tartrate Injection
Specification:
5%,10%,20%
Description:
Tylosin, a macrolide antibiotic, is active against particularly gram-positive bacteria, some
Spirochetes (including leptospira); actinomyces, mycoplasmas (pplo), haemophilus
Pertussis, moraxella bovis and some gram-negative cocci. after parenteral administration,
Therapeutically active blood-concentrations of tylosin are reached within 2 hours.
Indications:
Infections caused by micro-organisms susceptible to tylosin, like e.g. respiratory tract
Infections in cattle, sheep and pigs, dysentery doyle in pigs, dysentery and arthritis caused
by mycoplasmas, mastitis and endometritis.
Dosage And Administration:
For intramuscular administration.
General: 2mg-5mg tylosin, per 10 kg bodyweight daily, during 3-5 days.
Contraindications:
Hypersensitivity to tylosin.
Concurrent administration with penicillins, cephalosporines, quinolones and cycloserine.
Withdrawal Times:
Meat:8 days
Milk:4 days
Warning:
Keep out of the touch of children
Storage:
Store in a dry, dark place between 8°c and 15°c.
Product detail pictures:
Related Product Guide:
continue on to further improve, to make sure product top quality in line with market and consumer standard requirements. Our firm has a excellent assurance program have already been established for Hot sale Tilmicosin Injectable - Tylosin Tartrate Injection – Jizhong , The product will supply to all over the world, such as: Jamaica, Macedonia, Bolivia, We pay high attention to customer service, and cherish every customer. We have maintained a strong reputation in the industry for many years. We are honest and work on building a long-term relationship with our customers.
By Hilary from Armenia - 2017.01.11 17:15
This company can be well to meet our needs on product quantity and delivery time, so we always choose them when we have procurement requirements.
By Salome from Romania - 2017.08.28 16:02